ADCT
ADC Therapeutics SA
NYSE · Healthcare · Biotechnology · CH
$1.75
+12.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.98x
- Price / sales
- 2.83x
- Price / cash flow
- -2.18x
Enterprise value
- Enterprise value
- $420.8M
- EV / sales
- 5.34x
- EV / EBITDA
- -4.80x
- EV / EBIT
- -4.25x
- Market cap
- $222.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026